Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature
Skip Navigation Links
  • LRL Home
    • >
  • Mandate Search
    • >
  • Mandate Results

    • Mandated Reports - Search

    This database allows for searching of mandated reports that the Library is expecting or has received since 2003, with selected mandates prior to 2003 included. Searches by committee only cover 2019 to the present. Each year, the Legislature mandates reports and studies to be completed by state agencies or other governmental entities. Legislative Reference Library staff track these mandates and obtain copies of the reports for our collection in order to provide long-term access. All mandated reports that the library has acquired are searchable through our catalog. For more information, see Mandated Reports. Please notify Library staff with questions or concerns.


    Your search returned 53 results.
    Topics: Health Care - Pharmaceuticals

    For additional information, including links to the reports, click on "Details".

    Last Date ReceivedMandate DescriptionItem TitleAgencie(s)Session LawStatuteNext Due DateSubjects Committee/Agency Jurisdiction
    Details 08/22/2023 Summary of the results of each cost of dispensing survey and provide recommendations for any changes to the dispensing fee. The final cost of dispensing survey report shall be posted on the department's website. Minnesota Fee-for-Service Cost of Dispensing Survey Minn. Dept. of Human Services 2019 Minn. Laws 1st Sp. Sess. Chap. 9 Art. 7 Sec. 25 256B.0625 Subd. 13e(h) 01/01/2027 Health Care - Pharmaceuticals Medical Assistance Pharmacy Reimbursement
    Details 11/18/2024 Report that specifies which changes the board made to the controlled substance schedules maintained by the board in Minnesota Rules 6800.4210 to 6800.4250 in the preceding 12 months Report to the Legislature on Changes the Board Proposes to Make to the Controlled Substance Schedules Maintained by the Board in Minnesota Rules Minn. Board of Pharmacy 2009 Minn. Laws Chap. 59 Art. 5 Sec. 4 152.02 Subd. 12 12/01/2025 Health Care - Pharmaceuticals
    Details 11/25/2024 Report that aggregates data submitted to the Minn. Dept. of Health by covered entities related to their participation in the federal 340B program for the previous calendar year 340B Covered Entity Report: Report to the Legislature Minn. Dept. of Health 2024 Minn. Laws Chap. 127 Art. 59 Sec. 2 62J.461 Subd. 5 11/15/2025 Health Care - Medicare
    Health Care - Pharmaceuticals         		Health Care Finance and Policy
    Details 07/31/2024 Publish transparency reports on the Commerce Department website that have been submitted by pharmacy benefit managers, pertaining to plan sponsors doing business in Minnesota in the previous year Public Pharmacy Benefit Manager (PBM) Transparency Report Minn. Dept. of Commerce 2019 Minn. Laws Chap. 39 Art. Sec. 6 Subd. 2(b) 62W.06 Subd. 2(b) 08/01/2025 Health Care - Pharmaceuticals Corrections Policy and Finance
    Details Report making a determination as to whether the Minn. Management & Budget report mandated by 2021 Minn. Laws 1st Spl. Sess. Chap. 12 Art. 2 Sec. 8 (Minn. Stat. 43A.231 Subd. 5(a)) accurately compares: (1) actual, electronically adjudicated prescription drug costs under the first two years of the contract that begins on January 1, 2023, with a pharmacy benefit manager that was selected by the reverse auction; and (2) a projection of what prescription drug costs would have been for those same two years under the pharmacy benefit manager contract in effect from 2018 to 2022, with appropriate adjustment for any adopted formulary or beneficiary utilization changes. Minn. Legislature - Office of the Legislative Auditor 2021 Minn. Laws 1st Sp. Sess. Chap. 12 Art. 2 Sec. 8 43A.231 Subd. 5(c) 04/01/2025 Health Care - Pharmaceuticals State Government
    State Government Finance
    Details 03/01/2024 Report containing information provided by manufacturers of insulin, including the number of Minnesota residents who accessed and received insulin on an urgent-need basis in the preceding calendar year; the number of Minnesota residents participating in the manufacturer's patient assistance program in the preceding calendar year (and the number deemed ineligible); and the value of the insulin provided by the manufacturer. The report shall also include any administrative penalties assessed, including the name of the manufacturer and amount of the penalty. Report to the Legislature on the Minnesota Insulin Safety Net Program Minn. Board of Pharmacy 2020 Minn. Laws Chap. 73 Art. Sec. 4 Subd. 13(b) 151.74 Subd. 13(b) 03/15/2025 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details Report results of a comparison of: (1) actual, electronically adjudicated prescription drug costs under the first two years of the contract that begins on January 1, 2023, with a pharmacy benefit manager that was selected by the reverse auction; and (2) a projection of what prescription drug costs would have been for those same two years under the pharmacy benefit manager contract in effect from 2018 to 2022, with appropriate adjustment for any adopted formulary or beneficiary utilization changes. Minn. Management & Budget 2021 Minn. Laws 1st Sp. Sess. Chap. 12 Art. 2 Sec. 8 43A.231 Subd. 5(a) 03/01/2025 Health Care - Pharmaceuticals State Government
    State Government Finance
    Details 03/27/2024 Report on general price trends for prescription drug products and the number of prescription drug products that were subject to Prescription Drug Affordability Board cost review and analysis, including the result of any analysis as well as the number and disposition of appeals and judicial reviews. RE: Annual Report Minnesota's Prescription Drug Affordability Board Prescription Drug Affordability Board 2023 Minn. Laws Chap. 57 Art. 2 Sec. 36 62J.93 03/01/2025 Health Care - Pharmaceuticals Governor
    Details 07/01/2024 Report on the implementation of prescription drug price transparency under this section, including promoting transparency in pharmaceutical pricing for the state and other payers; enhancing the understanding on pharmaceutical spending trends; and assisting the state and other payers in the management of pharmaceutical costs.The report must include a summary of the information that drug manufacturers submit under Subs. 3, 4, and 5. Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature Minn. Dept. of Health 2020 Minn. Laws Chap. 78 Art. Sec. 1 Subd. 9 62J.84 Subd. 9 01/15/2025 Health Care - Costs & Financing
    Health Care - Pharmaceuticals         		Commerce
    Health and Human Services Policy and Finance
    Details Report on results of an assessment of licensed outpatient pharmacies and vendors of audible container labels and prescription readers, including: the approximate number of such pharmacies currently providing accessible labels to individuals who cannot access large print or Braille labels; the approximate cost to such pharmacies to provide accessible labels; and recommendations for providing accessible labels. Minn. Dept. of Health 2024 Minn. Laws Chap. 127 Art. 60 Sec. 24 01/15/2025 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details List of pharmacies that have informed the Minn. Dept. of Health they have the technological capacity to provide an accessible prescription drug container label to a patient in a timely manner, relative to the industry standard time required to produce the accessible container label. Minn. Dept. of Health 2024 Minn. Laws Chap. 127 Art. 60 Sec. 10 151.212 Subd. 4(d) 01/01/2025 Health Care - Pharmaceuticals
    Details 03/01/2024 Evaluation of the registration fee on drug manufacturers, and whether the registration fee and the increased licensure fees have reduced the number of opiate prescriptions issued in 2021, 2022, and 2023, or affected the availability of opiates for treating chronic or intractable pain. Report to the Legislature: Evaluation of Opiate Product Registration Fee & Increased Licensure Fees on Opiate Prescribing and Treating Chronic or Intractable Pain Minn. Board of Pharmacy 2019 Minn. Laws Chap. 63 Art. 1 Sec. 5 Subd. 4 151.066 Subd. 4 03/01/2024 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details 10/06/2023 Report on projects that receive grants and the overall role of the project in addressing the opioid addiction and overdose epidemic in Minnesota. Include recommendations on whether appropriations under this act should be continued, adjusted, or discontinued; whether funding should be appropriated for other purposes related to opioid abuse prevention, education, and treatment; and on the appropriate level of funding for existing and new uses. Legislative Report: Opioid Epidemic Response Advisory Council: Grant Award Update & Evidence Based Analysis of Opioid Legislative Appropriations Minn. Dept. of Human Services 2019 Minn. Laws Chap. 63 Art. 1 Sec. 7 256.042 Subd. 5(a) 01/31/2024 Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs         		Health and Human Services Policy and Finance
    Details 01/07/2022 Report on recommendations made by the opioid prescribing work group under Minnesota Statutes, section 256B.0638, subdivision 4, and steps taken by the commissioner of human services to implement the opioid prescribing improvement program under Minnesota Statutes, section 256B.0638, subdivision 5. Opioid Prescribing Improvement Program Minn. Dept. of Human Services 2015 Minn. Laws Chap. 71 Art. 11 Sec. 61 256B.0638 09/15/2022 Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs
    Details 02/25/2022 Overview of the Formulary Committee that includes: (1) a review of the current composition of and any recommended revisions to the membership of the committee; and (2) a summary of the committee's policies and procedures for the operation of the committee, opportunities for public input, providing public notice, and gathering public comments on the committee's recommendations and proposed actions. Proposed Drug Formulary Committee Minn. Dept. of Human Services 2021 Minn. Laws 1st Sp. Sess. Chap. 7 Art. 1 Sec. 35 03/01/2022 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details Report containing the results of surveys of individuals who have accessed urgent-need insulin through the Insulin Safety Net Program and are accessing or have accessed a manufacturers' patient assistance program; and of pharmacies that have dispensed insulin on an urgent-need basis under the program and have participated in the manufacturers' patient assistance programs. Minn. Dept. of Health 2020 Minn. Laws Chap. 73 Art. Sec. 4 Subd. 15(e) 01/15/2022 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details 02/03/2022 Report the results of a study to determine the appropriateness and feasibility of requiring mail order and specialty pharmacies to enclose in each medication's packaging a method by which the patient can easily detect improper storage or temperature variations that may have occurred during the delivery of a medication Report on a Study to Determine the Appropriateness and Feasibility of Requiring Mail Order and Specialty Pharmacies to Enclose in Each Medication's Packaging a Method by Which the Patient Can Easily Detect Improper Storage or Temperature Variations Minn. Board of Pharmacy 2021 Minn. Laws 1st Sp. Sess. Chap. 7 Art. 5 Sec. 5 01/15/2022 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details Post prescription drug price information on the Minn. Dept. of Health website in an easy-to-read format on a per-drug basis, allowing identification of the prescription drug, or contract with a private nonprofit entity or consortium to do so. Minn. Dept. of Health 2020 Minn. Laws Chap. 78 Art. Sec. 1 62J.84 Subd. 6 11/15/2021 Health Care - Costs & Financing
    Health Care - Pharmaceuticals
    Details 12/13/2021 Report on compliance with requirements for providers regarding electronic drug prior authorization standardization and transmission. Drug Prior Authorization Compliance: Report to the Minnesota Legislature Minn. Dept. of Health 2020 Minn. Laws Chap. 114 Art. 1 Sec. 04/01/2021 Health Care - Pharmaceuticals Health and Human Services Policy and Finance
    Details Report on results of evaluations analyzing changes in the number of opioid prescriptions, the number of emergency room visits related to opioid use, and other relevant measures, resulting from opioid abuse prevention pilot projects. Minn. Dept. of Health 2017 Minn. Laws 1st Sp. Sess. Chap. 6 Art. 10 Sec. 144 12/15/2019 Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs
    Details 02/16/2018 Report aggregate findings of the study of the use of opiates for the treatment of chronic pain conditions when acupuncture services are also part of the treatment for chronic pain as compared to opiate use among medical assistance recipients who are not receiving acupuncture. Is Acupuncture Associated with Reduced Opiate Use? A Review of Minnesota Medicaid Claims Minn. Dept. of Human Services 2017 Minn. Laws 1st Sp. Sess. Chap. 6 Art. 4 Sec. 63(b) 02/15/2018 Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs
    Details 01/07/2022 Report on the implementation of the opioid prescribing improvement program in the Minnesota health care programs. Opioid Prescribing Improvement Program Minn. Dept. of Human Services 2015 Minn. Laws Chap. 71 Art. 11 Sec. 30 256B.0638 Subd. 7 09/15/2017 Health Care - Pharmaceuticals
    Details 11/17/2016 Impact of the prescription monitoring program on doctor-shopping activities Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping Minn. Board of Pharmacy 2014 Minn. Laws Chap. 291 Art. 2 Sec. 4 12/15/2016 Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs
    Details 12/17/2015 Interstate prescription monitoring program Report to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program Minn. Board of Pharmacy 2014 Minn. Laws Chap. 291 Art. 2 Sec. 3 Subd. 6(g) 152.126 Subd. 6(g) 01/05/2016 Health Care - Pharmaceuticals
    Details 12/17/2015 Criteria for referring information about patients to prescribers and dispensers Report to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program Minn. Board of Pharmacy 2014 Minn. Laws Chap. 291 Art. 2 Sec. 3 Subd. 6(i) 152.126 Subd. 6(i) 01/05/2016 Health Care - Pharmaceuticals
    Details 12/11/2014 Specified topics relating to prescription monitoring and the prescription monitoring program database Report to the Legislature: Recommendations on Required Use and Other Uses of the MN Prescription Monitoring Program Database Minn. Board of Pharmacy 2014 Minn. Laws Chap. 291 Art. 2 Sec. 4 12/15/2014 Health Care - Pharmaceuticals
    Details 12/12/2014 Recommendations on the adoption of new prescription drug waste reduction techniques and technologies Prescription Drug Waste Reduction Report Minn. Board of Pharmacy 2010 Minn. Laws 1st Sp. Sess. Chap. 1 Art. 19 Sec. 21 12/15/2011 Health Care - Pharmaceuticals
    Details 01/26/2012 Recommendations to include veterinarians in the prescription electronic reporting system Report to the Legislature: Diversion of Controlled Substances Dispensed by Veterinary Practice Minn. Board of Pharmacy 2010 Minn. Laws 1st Sp. Sess. Chap. 1 Art. 19 Sec. 22 12/15/2011 Health Care - Pharmaceuticals
    Details 08/25/2011 Evaluation of the prescription electronic reporting system to determine if the system is cost-effective and whether it is negatively impacting appropriate prescribing practices of controlled substances Report to the Legislature: Impact of the Prescription Electronic Reporting System on Appropriate Prescribing Practices of Controlled Substances Minn. Board of Pharmacy 2007 Minn. Laws Chap. 147 Art. 11 Sec. 7 Subd. 8 152.126 Subd. 8b 07/15/2011 Health Care - Pharmaceuticals
    Details Plan posted on website that describes how the manufacturer supports the safe collection and proper disposal of the sharps generated by self-injected medications Pharmaceutical Manufacturer 2010 Minn. Laws Chap. 286 Art. Sec. 2 116.835 07/01/2011 Health Care - Pharmaceuticals
    Details Annual report of the Drug Utilization Review Board Minn. Dept. of Human Services 2009 Minn. Laws Chap. 173 Art. 3 Sec. 9 256B.0625 02/15/2011 Health Care - Pharmaceuticals
    Details 02/22/2010 Outline on how best to standardize drug prior authorization request transactions between providers and group purchasers Electronic Drug Prior Authorization Standardization and Transmission Minn. Dept. of Health 62J.497 Subd. 5 02/15/2010 Health Care - Pharmaceuticals
    Details Evaluation of whether participation in a multistate or multiagency drug purchasing program can reduce costs or improve the operations of the drug benefit programs Minn. Management & Budget 2003 Minn. Laws 1st Sp. Sess. Chap. 1 Art. 2 Sec. 61 43A.311 01/15/2010 Health Care - Pharmaceuticals
    Details 11/12/2009 Report on the effect of the subdivision requiring identification for schedule II or III controlled substances Report to the Legislature on the Effect of Requiring Identification for Schedule II and III Controlled Substance Prescriptions Minn. Board of Pharmacy 2007 Minn. Laws Chap. 147 Art. 12 Sec. 8 152.11 07/01/2009 Health Care - Pharmaceuticals
    Details 02/07/2008 Report on the fiscal impact of Deficit Reduction Act (DRA) Reforms on the Minnesota Medicaid pharmacy program Pharmacy Report on DRA Impact: Report to the Legislature Minn. Dept. of Human Services 2007 Minn. Laws Chap. 147 Art. 5 Sec. 38 01/15/2008 Health Care - Medicaid
    Health Care - Pharmaceuticals
    Details 02/04/2008 Recommendations and draft legislation on issues related to the prescription electronic reporting system Report to the Legislature on the Controlled Substances Prescription Electronic Reporting System Minn. Board of Pharmacy 2007 Minn. Laws Chap. 147 Art. 11 Sec. 7 Subd. 4 152.126 12/15/2007 Health Care - Pharmaceuticals
    Details 11/29/2007 Report on the appropriate prescribing of controlled substances Report of the Minnesota Board of Medical Practice Work Group on Appropriate Prescribing of Controlled Substances for Management of Pain Minn. Board of Medical Practice 2007 Minn. Laws Chap. 147 Art. 11 Sec. 26 12/15/2007 Health Care - Pharmaceuticals
    Details Evalulation of the overall effectiveness of the rural pharmacy planning and transition grant program Minn. Dept. of Health 2005 Minn. Laws 1st Sp. Sess. Chap. 4 Art. 6 Sec. 10 Subd. 5 08/01/2007 Health Care - Pharmaceuticals
    Health Care - Rural
    Details 02/09/2007 Findings of the study and the recommendations of the pharmacy payment reform advisory committee Implementation of Pharmacy Payment Reform in the Minnesota Medicaid Program: Recommendations to the Legislature Minn. Dept. of Human Services 2006 Minn. Laws Chap. 282 Art. 16 Sec. 15 Subd. 6 02/01/2007 Health Care - Pharmaceuticals
    Details 02/15/2007 Findings of the study and the recommendations of the pharmacy payment reform advisory committee Pharmacy Reimbursement: Report to the Legislature Minn. Dept. of Human Services 2006 Minn. Laws Chap. 282 Art. 16 Sec. 15 Subd. 6 02/01/2007 Health Care - Pharmaceuticals
    Details 03/21/2006 Study of feasibility of a centralized computer or electronic system to enable pharmacies to carry out their duties Methamphetamine - Electronic Monitoring Report to the Legislature Minn. Dept. of Public Safety 2005 Minn. Laws Chap. 136 Art. 7 Sec. 19 02/01/2006 Health Care - Pharmaceuticals
    Details 02/25/2005 Proposal for a competency-based education and assessment program for professionals authorized to prescribe, dispense or administer legend drugs Expanding Authority to Prescribe, Administer, or Dispense Pharmaceuticals: A Proposal Minn. Board of Pharmacy 2004 Minn. Laws Chap. 242 Art. Sec. 3 01/30/2005 Health Care - Pharmaceuticals
    Details Review of prior authorization of prescription drugs in the fee-for-service medical assistance program Minn. Dept. of Human Services 2002 Minn. Laws Chap. 375 Art. 2 Sec. 52 01/15/2004 Health Care - Medicaid
    Health Care - Pharmaceuticals
    Details Report assessing the cost savings that could be generated by the mail order dispensing of prescription drugs to recipients of medical assistance, general assistance medical care, and the prescription drug program Minn. Dept. of Human Services 2003 Minn. Laws 1st Sp. Sess. Chap. 14 Art. 12 Sec. 97 01/07/2004 Health Care - Medicaid
    Health Care - Pharmaceuticals
    Details Preferred drug list Minn. Dept. of Human Services 2003 Minn. Laws 1st Sp. Sess. Chap. 14 Art. 12 Sec. 35 Subd. 13(g) 01/01/2004 Health Care - Pharmaceuticals
    Details 11/20/1998 Biennial report on the activities of the State Board of Pharmacy Biennial Report of the Board of Pharmacy Minn. Board of Pharmacy 214.07 Subd. 1b 10/15/2000 Governing/Government-State - Agencies
    Health Care - Pharmaceuticals
    Details Information on prescription drug prices Office of the Attorney General 1997 Minn. Laws Chap. 202 Art. 2 Sec. 35 62J.685 03/01/1998 Health Care - Pharmaceuticals
    Details 03/18/2022 Report on promising practices or theory-based projects selected for evaluation that address opioid addiction and the overdose epidemic, after an evaluation study is complete. Evaluation of a Buprenorphine Boot Camp Training Program for Healthcare Providers in Minnesota Minn. Management & Budget 2019 Minn. Laws Chap. 63 Art. 1 Sec. 7 256.042 Subd. 5(b)   Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs         		Health and Human Services Policy and Finance
    Details 07/19/2022 Report on promising practices or theory-based projects selected for evaluation that address opioid addiction and the overdose epidemic, after an evaluation study is complete. Evaluation of Peer Recovery Services for Substance Use Disorder in Minnesota: Impact of Peer Recovery on SUD Treatment and Recovery Minn. Management & Budget 2019 Minn. Laws Chap. 63 Art. 1 Sec. 7 256.042 Subd. 5(b)   Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs         		Health and Human Services Policy and Finance
    Details 09/30/2021 Report on promising practices or theory-based projects selected for evaluation that address opioid addiction and the overdose epidemic, after an evaluation study is complete. Evaluation of ECHO Programs in Minnesota: Impact of Project ECHO on Opioid Use Disorder Treatment Minn. Management & Budget 2019 Minn. Laws Chap. 63 Art. 1 Sec. 7 256.042 Subd. 5(b)   Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs         		Health and Human Services Policy and Finance
    Details 09/30/2021 Report on promising practices or theory-based projects selected for evaluation that address opioid addiction and the overdose epidemic, after an evaluation study is complete. Minnesota's Early Opioid Policy Response: Impact of Policies to Curtail Opioid Prescribing Minn. Management & Budget 2019 Minn. Laws Chap. 63 Art. 1 Sec. 7 256.042 Subd. 5(b)   Health Care - Pharmaceuticals
    Substance Use/Misuse - Opioids & Other Drugs         		Health and Human Services Policy and Finance
    Details Program review of whether manufacturers are reimbursing pharmacies for urgent-need insulin; determining eligibility in a timely manner and notifying individuals; and providing pharmacies with insulin product under the manufacturers' patient assistance program; whether training for navigators is adequate and accessible, and whether there is a sufficient number of trained navigators. Minn. Legislature - Office of the Legislative Auditor 2020 Minn. Laws Chap. 73 Art. Sec. 4 Subd. 14 151.74 Subd. 14   Health Care - Pharmaceuticals
    Details Post a report on the Minn. Dept. of Health website describing any prescription drug price information the Minn. Dept. of Health has withheld from public disclosure, the nature of the information, and the basis for withholding the information. Minn. Dept. of Health 2020 Minn. Laws Chap. 78 Art. Sec. 1 62J.84 Subd. 6(d)   Health Care - Pharmaceuticals